Abstract
Rheumatology was first recognized as a distinct clinical specialty in Korea just 35 years ago. Young professors who were trained in rheumatology in the USA and afterwards returned to Korea contributed substantially to advances in rheumatology clinical practice, educational programmes and research activities. They also established the Korean Rheumatism Association, later renamed the Korean College of Rheumatology. These young rheumatologists had a major role not only in raising the level of clinical and scientific activities, but also in promoting academic exchanges around the Asia–Pacific region, the USA and Europe. Subsequently, Korea's rapid economic growth and high education level enabled rheumatology to advance rapidly. Today, continued efforts are required to raise the standard of clinical and basic research, to optimize clinical practice with regard to new biologic agents, to exploit personalized and targeted therapies for the rheumatic diseases, and to meet the medical demands of Korea's ageing society.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Park, M. H., Juji, T. & Tokunaga, K. HLA ethnic study of Japanese and Koreans. In HLA 1991 (eds Tsuji, K. et al.) Vol 1. 674–676 (Oxford University Press, 1992).
Jeon, C. H. et al. Pulmonary hypertension associated with rheumatic diseases: baseline characteristics from the Korean registry. Int. J. Rheum. Dis. 15, e80–e89 (2012).
Bang, D. S. et al. Epidemiologic and clinical survey of Behçet's disease in Korea: the first multicenter study. J. Korean Med. Sci. 16, 615–618 (2001).
Kim, I. et al. The prevalence of knee osteoarthritis in elderly community residents in Korea. J. Korean. Med. Sci. 25, 293–298 (2010).
Lawrence, R. C. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 58, 26–35 (2008).
Cho, H. J. et al. Gender and prevalence of knee osteoarthritis types in elderly Koreans. J. Arthroplasty 26, 994–999 (2011).
Kim, H. A. et al. The epidemiology of total knee replacement in South Korea: national registry data. Rheumatology (Oxford) 47, 88–91 (2008).
Helmick, C. G. et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 58, 15–25 (2008).
Sung, Y. K., Cho, S. K., Choi, C. B. & Bae, S. C. Prevalence and incidence of rheumatoid arthritis in South Korea. Rheumatol. Int. 33, 1525–1532 (2013).
Sung, Y. K. et al. Korean Observational Study Network for Arthritis (KORONA): establishment of a prospective multicenter cohort for rheumatoid arthritis in South Korea. Semin. Arthritis Rheum. 41, 745–751 (2012).
Park, Y. B. et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum. 46, 1714–1719 (2002).
Park, Y. B. et al. Lipid profiles in untreated patients with rheumatoid arthritis. J. Rheumatol. 26, 1701–1704 (1999).
Dougados, M. et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann. Rheum. Dis. 73, 62–68 (2014).
Kim, H. Y. et al. Predominance of HLA-DRB1*0405 in Korean patients with rheumatoid arthritis. Ann. Rheum. Dis. 54, 988–990 (1995).
Lee, H. S. et al. Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations. Arthritis Rheum. 60, 364–371 (2009).
Kim, K. et al. High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci. Ann. Rheum. Dis. 74, e13 (2015).
Ju, J. H. et al. Prevalence of systemic lupus erythematosus in South Korea: an administrative database study. J. Epidemiol. 24, 295–303 (2014).
Shim, J. S., Sung, Y. K., Joo, Y. B., Lee, H. S. & Bae, S. C. Prevalence and incidence of systemic lupus erythematosus in South Korea. Rheumatol. Int. 34, 909–917 (2014).
Lee, H. S. et al. Ethnic specificity of lupus-associated loci identified in a genome-wide association study in Korean women. Ann. Rheum. Dis. 73, 1240–1245 (2014).
Kim, K. et al. The HLA-DRβ1 amino acid positions 11-13-26 explain the majority of SLE–MHC associations. Nat. Commun. 5, 5902 (2014).
Choi, B. Y., Yoon, M. J., Shin, K., Lee, Y. J. & Song, Y. W. Characteristics of pleural effusions in systemic lupus erythematosus: differential diagnosis of lupus pleuritis. Lupus 24, 321–326 (2015).
Ju, J. H. et al. Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE. Nat. Rev. Rheumatol. 5, 273–281 (2009).
Park, E. J. et al. Pregnancy outcomes in patients with systemic lupus erythematosus: a retrospective review of 62 pregnancies at a single tertiary center in South Korea. Int. J. Rheum. Dis. 17, 887–897 (2014).
Koh, J. H., Ko, H. S., Kwok, S. K., Ju, J. H. & Park, S. H. Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus. Lupus 24, 210–217 (2015).
Kang, K. Y. et al. The causes of death in Korean patients with systemic lupus erythematosus over 11 years. Lupus 20, 989–997 (2011).
Kang, K. Y. et al. Impact of interleukin-21 in the pathogenesis of primary Sjögren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands. Arthritis Res. Ther. 13, R179 (2011).
Kwok, S. K. et al. A pathogenetic role for IL-21 in primary Sjögren syndrome. Nat. Rev. Rheumatol. 11, 368–374 (2015).
Zhou, X. et al. HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans. Arthritis Rheum. 60, 3807–3814 (2009).
Cho, K. S. et al. Adult onset Still's disease: clinical features and prognostic factors in Korea. J. Korean Rheum. Assoc. 5, 64–75 (1998).
Kim, T. J. & Kim, T. H. Clinical spectrum of ankylosing spondylitis in Korea. Joint Bone Spine 77, 235–240 (2010).
Lee, J. H. et al. Higher prevalence of peripheral arthritis among ankylosing spondylitis patients. J. Korean Med. Sci. 17, 669–673 (2002).
Baek, H. J. et al. Juvenile onset ankylosing spondylitis (JAS) has less severe spinal disease course than adult onset ankylosing spondylitis (AAS): clinical comparison between JAS and AAS in Korea. J. Rheumatol. 29, 1780–1785 (2002).
Roh, E. Y. et al. HLA-A, -B, -DR allele frequencies and haplotypic associations in Koreans defined by generic-level DNA typing. Korean J. Lab. Med. 23, 420–430 (2003).
Park, K. S., Kang, S. Y. & Lee, W. I. HLA-B27 subtypes in Korean patients with ankylosing spondylitis [Korean]. Korean J. Lab. Med. 28, 46–52 (2008).
Bang, D. S., Oh, S. H., Lee, K. H., Lee, E. S. & Lee, S. N. Influence of sex on patients with Behçet's disease in Korea. J. Korean Med. Sci. 18, 231–235 (2003).
Lee, Y. J. et al. Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behçet's disease. Ann. Rheum. Dis. 72, 1510–1516 (2013).
Ju, J. H. et al. Modulation of STAT-3 in rheumatoid synovial T cells suppresses TH17 differentiation and increases the proportion of TREG cells. Arthritis Rheum. 64, 3543–3552 (2012).
Kim, D. Y., Choi, M. J., Cho, S., Kim, D. W. & Bang, D. Changing clinical expression of Behçet disease in Korea during three decades (1983–2012): chronological analysis of 3674 hospital-based patients. Br. J. Dermatol. 170, 458–461 (2014).
Park, D. J. et al. Cost-effectiveness analysis of HLA-B5801 genotyping in the treatment of gout patients with chronic renal insufficiency in Korea. Arthritis Care Res. (Hoboken) 67, 280–287 (2015).
Kim, H. Y. et al. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII255–274 in patients with rheumatoid arthritis. Arthritis Rheum. 42, 2085–2093 (1999).
Kim, K. W. et al. Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L–CD40 interaction. Arthritis Rheum. 56, 1076–1086 (2007).
Cho, M. L. et al. Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: cross-talk between T cells and synovial fibroblasts. Arthritis Rheum. 50, 776–784 (2004).
Min, D. J. et al. Augmented production of chemokines by the interaction of type II collagen-reactive T cells with rheumatoid synovial fibroblasts. Arthritis Rheum. 50, 1146–1155 (2004).
Lee, J., Sim, J. H. & Kim, I. J. Peripheral immature B cells: modulators of autoimmunity. Int. J. Rheum. Dis. 18, 200–207 (2014).
Park, S. H. et al. Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis. Arthritis Rheum. 44, 561–569 (2001).
Yoo, S. A. et al. A novel pathogenic role of the ER chaperone GRP78/BiP in rheumatoid arthritis. J. Exp. Med. 209, 871–886 (2012).
Yoon, H. J. et al. NF-AT5 is a critical regulator of inflammatory arthritis. Arthritis Rheum. 63, 1843–1852 (2011).
Cho, M. L. et al. STAT3 and NF-κB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J. Immunol. 176, 5652–5661 (2006).
Park, J. S. et al. p53 controls autoimmune arthritis via STAT-mediated regulation of the TH17 cell/TREG cell balance in mice. Arthritis Rheum. 65, 949–959 (2013).
Min, S. Y. et al. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen. Arthritis Res. Ther. 6, R213–R219 (2004).
Kang, Y. M. et al. CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J. Exp. Med. 195, 1325–1336 (2002).
Kim, Y. G. et al. Effect of interleukin-32γ on differentiation of osteoclasts from CD14+ monocytes. Arthritis Rheum. 62, 515–523 (2010).
Mun, S. H. et al. Interleukin-33 stimulates formation of functional osteoclasts from human CD14+ monocytes. Cell. Mol. Life Sci. 67, 3883–3892 (2010).
Hwang, S. J. et al. Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis. Arthritis Res. Ther. 14, R14 (2012).
Min, S. Y. et al. Antigen-induced, tolerogenic CD11c+, CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis. Arthritis Rheum. 54, 887–898 (2006).
Park, M. J. et al. Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model. Arthritis Res. Ther. 10, R11 (2008).
Kwak, H. B. et al. Reciprocal cross-talk between RANKL and interferon-γ-inducible protein 10 is responsible for bone-erosive experimental arthritis. Arthritis Rheum. 58, 1332–1342 (2008).
Lee, E. Y., Lee, Z. H. & Song, Y. W. CXCL10 and autoimmune diseases. Autoimmun. Rev. 8, 379–383 (2009).
Kim, K. W. et al. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthritis Rheum. 64, 1015–1023 (2012).
Oh, J. et al. Progranulin and a five transmembrane domain-containing receptor-like gene are the key components in receptor activator of nuclear factor κB (RANK)-dependent formation of multinucleated osteoclasts. J. Biol. Chem. 290, 2042–2052 (2015).
Ju, J. H. et al. IL-23 induces receptor activator of NF-κB ligand expression on CD4+ T cells and promotes osteoclastogenesis in an autoimmune arthritis model. J. Immunol. 181, 1507–1518 (2008).
Kim, H. R. et al. Reciprocal activation of CD4+ T cells and synovial fibroblasts by stromal cell-derived factor 1 promotes RANKL expression and osteoclastogenesis in rheumatoid arthritis. Arthritis Rheumatol. 66, 538–548 (2014).
Cho, Y. N. et al. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus. J. Immunol. 193, 3891–3901 (2014).
Park, Y. W. et al. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis Rheum. 60, 1753–1763 (2009).
Lee, S. W. et al. Cilostazol protects rat chondrocytes against nitric oxide-induced apoptosis in vitro and prevents cartilage destruction in a rat model of osteoarthritis. Arthritis Rheum. 58, 790–800 (2008).
Lee, S. W. et al. TRAIL induces apoptosis of chondrocytes and influences the pathogenesis of experimentally induced rat osteoarthritis. Arthritis Rheum. 50, 534–542 (2004).
Liang, G., Ahlqvist, K., Pannem, R., Posern, G. & Massoumi, R. Serum response factor controls CYLD expression via MAPK signaling pathway. PLoS ONE 6, e19613 (2011).
Aigner, T. & Kim, H. A. Apoptosis and cellular vitality: issues in osteoarthritic cartilage degeneration. Arthritis Rheum. 46, 1986–1996 (2002).
Kim, H. A. et al. The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum. 54, 2152–2163 (2006).
Yoon, C. H. et al. Validity of the sonographic longitudinal sagittal image for assessment of the cartilage thickness in the knee osteoarthritis. Clin. Rheumatol. 27, 1507–1516 (2008).
Lee, J., Kim, H.-R., Lee, S. H. & Kim, H.-Y. Epigenetic modification in systemic rheumatic diseases. J. Rheum. Dis. 20, 140–148 (2013).
You, S. et al. A systems approach to rheumatoid arthritis. PLoS ONE 7, e51508 (2012).
Kang, Y. M. et al. LIGHT up-regulated on B lymphocytes and monocytes in rheumatoid arthritis mediates cellular adhesion and metalloproteinase production by synoviocytes. Arthritis Rheum. 56, 1106–1117 (2007).
Nam, E. J. et al. A matrix metalloproteinase 1-cleavable composite peptide derived from transforming growth factor β-inducible gene H3 potently inhibits collagen-induced arthritis. Arthritis Rheum. 65, 1753–1763 (2013).
Lee, J. et al. Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritis. Arthritis Res. Ther. 16, R41 (2014).
Navarra, S. V. et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 377, 721–731 (2011).
Acknowledgements
The authors acknowledge Professor Andrew. H. Kang (University of Tennessee, School of Medicine, Memphis, Tennessee, USA) not only for his tireless efforts in training and education in rheumatology for young Korean internists, but also for his tremendous support and promotion of international affairs, as well as encouragement of research activities, in the past 30 years. We also thank Drs C. S. Cho, D. H. Yoo, S. C. Bae, T. H. Kim, S. K. Lee, E. M. Koh, W. U. Kim, M. H. Park, S. H. Lee and H. R. Kim for their help with data acquisition and manuscript preparation. The opinions expressed in this article are solely those of the authors and do not reflect the views of KCR.
Author information
Authors and Affiliations
Contributions
Both authors contributed equally to all aspects of the preparation of this manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kim, HY., Song, YW. The dynamic evolution of rheumatology in Korea. Nat Rev Rheumatol 12, 183–189 (2016). https://doi.org/10.1038/nrrheum.2015.165
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2015.165
This article is cited by
-
Moving towards online rheumatology education in the era of COVID-19
Clinical Rheumatology (2020)
-
Healthcare disparities in rheumatology: the role of education at a global level
Clinical Rheumatology (2020)
-
Rheumatology in Egypt: back to the future
Rheumatology International (2019)